Skip to main content
SpringerLink
Log in

Reply to In support of the European Union biosimilar framework

  • Correspondence
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schneider, C. et al. Nat. Biotechnol. 30, 744–746 (2012).

    Google Scholar 

  2. Schellekens, H. & Moors, E. Nat. Biotechnol. 28, 28–31 (2010).

    Article  CAS  Google Scholar 

  3. European Medicine Agency. Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues EMEA/CHMP/BWP/49348/2005 (2006). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003953.pdf

  4. European Medicine Agency. Withdrawal assessment report Marvel insulin (2010). http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/2010/01/WC500067086.pdf

  5. European Medicines Agency. European public assessment report (EPAR) for Alpheon (2007). http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/000585/WC500017451.pdf

  6. Hermeling, S., Jiskoot, W., Crommelin, D., Bornaes, C. & Schellekens, H. Pharm. Res. 22, 847–851 (2005).

    Article  CAS  Google Scholar 

  7. Prümmer, O. Biotherapy 10, 15–24 (1997).

    Article  Google Scholar 

  8. Baumann, A. . Curr. Drug Metab. 7, 15–21 (2006).

    Article  CAS  Google Scholar 

  9. Mahmood, I. & Green, M.D. Clin. Pharmacokinet. 44, 331–347 (2005).

    Article  CAS  Google Scholar 

  10. European Medicine Agency. European public assessment report Avonex (2006). http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000102/WC500029420.pdf

  11. Alam, J. et al. Pharm. Res. 14, 546–549 (1997).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Danish Health and Medicines Authority, Copenhagen, Denmark

    Christian K Schneider

  2. Twincore Centre for Experimental and Clinical Infection Research, Hannover, Germany

    Christian K Schneider

  3. Medicines Authority, Gzira, Malta

    John J Borg

  4. European Medicines Agency (EMA), London, UK

    Falk Ehmann, Klara Tiitso & Camille Vleminckx

  5. Finnish Medicines Agency (FIMEA), Helsinki, Finland

    Niklas Ekman & Esa Heinonen

  6. Swissmedic, Bern, Switzerland

    Esa Heinonen

  7. Agence nationale de securité du médicament et des produits de santé (ANSM), Paris, France

    Kowid Ho & Jean-Hugues Trouvin

  8. Medicines Evaluation Board (CBG-MEB), Utrecht, The Netherlands

    Marcel H Hoefnagel, Roeland Martijn van der Plas & Antonius J van der Stappen

  9. Spanish Medicines Agency (AEMPS), Madrid, Spain

    Sol Ruiz

  10. National Institute for Biological Standards and Control (NIBSC), Hertfordshire, UK

    Robin Thorpe

  11. Aristotle University of Thessaloniki, Thessaloniki, Greece

    Asterios S Tsiftsoglou

  12. Austrian Medicines and Medical Devices Agency (AGES), Vienna, Austria

    Guenter Waxenecker

  13. Medical Products Agency (MPA), Uppsala, Sweden

    Mats Welin

  14. Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), Bonn, Germany

    Martina Weise

  15. University Paris Descartes, Paris, France

    Jean-Hugues Trouvin

Authors
  1. Christian K Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John J Borg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Falk Ehmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Niklas Ekman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Esa Heinonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kowid Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Marcel H Hoefnagel
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Roeland Martijn van der Plas
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sol Ruiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Antonius J van der Stappen
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Robin Thorpe
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Klara Tiitso
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Asterios S Tsiftsoglou
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Camille Vleminckx
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Guenter Waxenecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Mats Welin
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Martina Weise
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Jean-Hugues Trouvin
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Working Party on Similar Biological (Biosimilar) Medicinal Products (BMWP)

Biologicals Working Party (BWP) of the Committee for Medicinal Products for Human Use (CHMP)

Corresponding author

Correspondence to Christian K Schneider.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schneider, C., Borg, J., Ehmann, F. et al. Reply to In support of the European Union biosimilar framework. Nat Biotechnol 30, 748–749 (2012). https://doi.org/10.1038/nbt.2327

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2327

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation